Cargando…
Using Tolvaptan to Treat Hyponatremia: Results from a Post-authorization Pharmacovigilance Study
INTRODUCTION: Hyponatremia is a common condition of varying etiology among hospitalized patients and is associated with adverse outcomes. Treatment to normalize serum sodium is advisable. Tolvaptan received European Union marketing authorization for hyponatremia secondary to the syndrome of inapprop...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572184/ https://www.ncbi.nlm.nih.gov/pubmed/34693505 http://dx.doi.org/10.1007/s12325-021-01947-9 |